Overview

A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy and safety of orforglipron on maintenance of body weight reduction.
Phase:
PHASE3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
orforglipron